PMID- 17151278 OWN - NLM STAT- MEDLINE DCOM- 20061229 LR - 20200225 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 26 IP - 49 DP - 2006 Dec 6 TI - Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. PG - 12748-57 AB - Brain-derived neurotrophic factor (BDNF) polymorphism is associated with the pathophysiology of several neurodegenerative disorders, including Huntington's disease. In view of these data and the involvement of huntingtin in intracellular trafficking, we examined the intracellular transport and release of Val66Val BDNF (Val-BDNF) and Val66Met BDNF (Met-BDNF) in transfected striatal knock-in cells expressing wild-type or mutant full-length huntingtin. Colocalization studies with specific markers for endoplasmic reticulum showed no differences between the Val-BDNF and Met-BDNF and were not modified by mutant huntingtin. However, post-Golgi trafficking was altered by mutant huntingtin dependent on the BDNF form. Thus, fluorescence recovery after photobleaching (FRAP) and inverse FRAP analysis showed retention of Met-BDNF in the Golgi apparatus with respect to Val-BDNF in wild-type cells. Strikingly, mutant huntingtin diminished post-Golgi trafficking of Val-BDNF, whereas Met-BDNF was not modified. Accordingly, a reduction in the number of transport vesicles was only observed in mutant huntingtin cells transfected with Val-BDNF but not Met-BDNF. Moreover, mutant huntingtin severely affected the KCl-evoked release of Val-BDNF, although it had little effect on Met-BDNF regulated release. The constitutive release of Val-BDNF or Met-BDNF in mutant cells was only slightly reduced. Interestingly, mutant huntingtin only perturbed post-Golgi trafficking of proteins that follow the regulated secretory pathway (epidermal growth factor receptor or atrial natriuretic factor), whereas it did not change those that follow the constitutive pathway (p75(NTR)). We conclude that mutant huntingtin differently affects intracellular transport and release of Val-BDNF and Met-BDNF. In addition, our findings reveal a new role for huntingtin in the regulation of the post-Golgi trafficking of the regulated secretory pathway. FAU - del Toro, Daniel AU - del Toro D AD - Departament de Biologia Cel.lular i Anatomia Patologica, Facultat de Medicina, Institut d'Investigacions Biomediques August Pi i Sunyer, Universitat de Barcelona, 08036 Barcelona, Spain. FAU - Canals, Josep M AU - Canals JM FAU - Gines, Silvia AU - Gines S FAU - Kojima, Masami AU - Kojima M FAU - Egea, Gustavo AU - Egea G FAU - Alberch, Jordi AU - Alberch J LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (HTT protein, human) RN - 0 (Huntingtin Protein) RN - 0 (Nerve Tissue Proteins) RN - 0 (Nuclear Proteins) RN - AE28F7PNPL (Methionine) RN - HG18B9YRS7 (Valine) SB - IM MH - Amino Acid Substitution/genetics MH - Animals MH - Brain-Derived Neurotrophic Factor/*genetics/*metabolism MH - Cell Line MH - Cell Line, Transformed MH - Golgi Apparatus/*physiology MH - Humans MH - Huntingtin Protein MH - Huntington Disease/genetics/metabolism MH - Methionine/genetics MH - Mice MH - Mice, Mutant Strains MH - *Mutation MH - Nerve Tissue Proteins/*genetics/physiology MH - Nuclear Proteins/*genetics/physiology MH - *Polymorphism, Single Nucleotide MH - Protein Transport/genetics MH - Signal Transduction/genetics MH - Valine/genetics PMC - PMC6674849 EDAT- 2006/12/08 09:00 MHDA- 2006/12/30 09:00 PMCR- 2007/06/06 CRDT- 2006/12/08 09:00 PHST- 2006/12/08 09:00 [pubmed] PHST- 2006/12/30 09:00 [medline] PHST- 2006/12/08 09:00 [entrez] PHST- 2007/06/06 00:00 [pmc-release] AID - 26/49/12748 [pii] AID - 3169893 [pii] AID - 10.1523/JNEUROSCI.3873-06.2006 [doi] PST - ppublish SO - J Neurosci. 2006 Dec 6;26(49):12748-57. doi: 10.1523/JNEUROSCI.3873-06.2006.